Cargando…

What Is New in Cutaneous T Cell Lymphoma?

PURPOSE OF REVIEW: This review focuses on updates in prognosis, pathogenesis, and treatment of cutaneous T cell lymphoma (CTCL). RECENT FINDINGS: Cohort studies indicate imaging may be necessary in early-stage CTCL. Risk factors for progression of CTCL have been identified. Interactions between mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgenroth, Sarah, Roggo, Andrea, Pawlik, Laura, Dummer, Reinhard, Ramelyte, Egle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640416/ https://www.ncbi.nlm.nih.gov/pubmed/37874473 http://dx.doi.org/10.1007/s11912-023-01464-8

Ejemplares similares

Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma
por: Lang, Claudia C. V., et al.
Publicado: (2020)

Recurrent squamous cell carcinoma of the perianal skin: a case report
por: Staeger, Ramon, et al.
Publicado: (2020)

Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
por: Pawlik, Laura, et al.
Publicado: (2023)

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023)

Swiss Recommendations for Cutaneous Basal Cell Carcinoma
por: Ramelyte, Egle, et al.
Publicado: (2022)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center
por: Grossmann, Lara E., et al.
Publicado: (2022)

Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report
por: Schön, Viola, et al.
Publicado: (2023)

Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome
por: Simic, Dario, et al.
Publicado: (2021)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Collection and preprocessing of fine needle aspirate patient samples for single cell profiling and data analysis
por: Tastanova, Aizhan, et al.
Publicado: (2021)

The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma
por: Boerlin, Aurelio, et al.
Publicado: (2022)

Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden
por: Ak, Melike, et al.
Publicado: (2021)

Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis
por: Kraehenbuehl, Lukas, et al.
Publicado: (2023)

Sarcoidosis and cutaneous lymphoma: What is the relationship?
por: Gargallo, Vanessa, et al.
Publicado: (2017)

Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042
por: Accart, Nathalie, et al.
Publicado: (2013)

New Targeted Treatments for Cutaneous T-cell Lymphomas
por: Bagot, Martine
Publicado: (2017)

Cutaneous T-cell lymphoma
por: Arora, Shalabh, et al.
Publicado: (2020)

Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis
por: Dimitriou, Florentia, et al.
Publicado: (2020)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
por: Fujii, Kazuyasu
Publicado: (2018)

What's new in peripheral T‐cell lymphomas
por: Luminari, Stefano, et al.
Publicado: (2021)

Cutaneous T-Cell Lymphoma in Asians
por: Jang, Min Soo, et al.
Publicado: (2012)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Chemotherapy in Cutaneous Melanoma: Is There Still a Role?
por: Pham, James P., et al.
Publicado: (2023)

Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2019)

TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
por: Dreno, Brigitte, et al.
Publicado: (2014)

An overview of cutaneous T cell lymphomas
por: Bagherani, Nooshin, et al.
Publicado: (2016)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

Primary Cutaneous B-Cell Lymphomas: An Update
por: Vitiello, Paola, et al.
Publicado: (2020)

Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
por: Vašků, Vladimír, et al.
Publicado: (2022)

Genomic landscape of cutaneous T cell lymphoma
por: Choi, Jaehyuk, et al.
Publicado: (2015)

Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches
por: Tanase, Cristiana, et al.
Publicado: (2019)

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
por: Li, Janet Y, et al.
Publicado: (2012)

CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
por: Giustiniani, Jérôme, et al.
Publicado: (2022)

Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
por: Ion, Alexandra, et al.
Publicado: (2016)

Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
por: Sugaya, Makoto
Publicado: (2021)

Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
por: Warda, Ankedo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sve2q1fvb0pqdindg3oq59kpfl